778TiPIpilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217). (23rd October 2018) - Goekkurt, E; Binder, M; Lorenzen, S; Thuss-Patience, P C; Al-Batran, S-E; Hinke, A; Hegewisch-Becker, S; Nilsson, S; Bokemeyer, C; Stein, A